TherOx is a private, venture financed medical device company based in Irvine, California.

TherOx  core technology for the treament of heart attack consists of dissolving and stabilizing hyper-elevated concentrations of oxygen in saline solution.  A small amount of the saline solution is then mixed with the patient's blood to create super oxygenated blood.

TherOx's DownStream® System creates and infuses super oxygenated blood through a catheter to oxygen deficient or ischemic tissue.  Company research has confirmed in pre-clinical studies that SuperSaturated Oxygen Therapy can reverse ischemia and resuscitate tissue that would otherwise die.

Working with leading scientific and clinical advisors, the company is conducting a clinical trial with SuperSaturated Oxygen Therapy to treat a high risk group of heart attack patients.